Global Sodium Iodide (131I) Diagnostic Capsules Market Growth 2024-2030

Global Sodium Iodide (131I) Diagnostic Capsules Market Growth 2024-2030

Sodium iodide (131I) diagnostic capsule is a radioactive drug used for the diagnosis of thyroid disease-related diseases. Iodine-131 (131I, I-131) is an important radioisotope of iodine discovered by Glenn Seaborg and John Livingood in 1938 at the University of California, Berkeley. It has a radioactive decay half-life of about eight days. It is associated with nuclear energy, medical diagnostic and treatment procedures, and natural gas production.

The global Sodium Iodide (131I) Diagnostic Capsules market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Sodium Iodide (131I) Diagnostic Capsules Industry Forecast” looks at past sales and reviews total world Sodium Iodide (131I) Diagnostic Capsules sales in 2023, providing a comprehensive analysis by region and market sector of projected Sodium Iodide (131I) Diagnostic Capsules sales for 2024 through 2030. With Sodium Iodide (131I) Diagnostic Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sodium Iodide (131I) Diagnostic Capsules industry.

This Insight Report provides a comprehensive analysis of the global Sodium Iodide (131I) Diagnostic Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sodium Iodide (131I) Diagnostic Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sodium Iodide (131I) Diagnostic Capsules market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sodium Iodide (131I) Diagnostic Capsules and breaks down the forecast by Specification, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sodium Iodide (131I) Diagnostic Capsules.

United States market for Sodium Iodide (131I) Diagnostic Capsules is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Sodium Iodide (131I) Diagnostic Capsules is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Sodium Iodide (131I) Diagnostic Capsules is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Sodium Iodide (131I) Diagnostic Capsules players cover Jubilant Radiopharma, Beijing Atom High-Tech, Curium Pharma, NTP Radioisotopes, PDRadiopharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Sodium Iodide (131I) Diagnostic Capsules market by product type, application, key manufacturers and key regions and countries.

Segmentation by Specification:
0.333MBq
3.7MBq
Others

Segmentation by Application:
Hyperthyroidism
Thyroid Cancer

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Jubilant Radiopharma
Beijing Atom High-Tech
Curium Pharma
NTP Radioisotopes
PDRadiopharma

Key Questions Addressed in this Report

What is the 10-year outlook for the global Sodium Iodide (131I) Diagnostic Capsules market?

What factors are driving Sodium Iodide (131I) Diagnostic Capsules market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Sodium Iodide (131I) Diagnostic Capsules market opportunities vary by end market size?

How does Sodium Iodide (131I) Diagnostic Capsules break out by Specification, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.